Cuu Long Pharmaceutical JSC (HOSE:DCL)
Vietnam · Delayed Price · Currency is VND 44,950
-950 (-2.07%)
At close: Sep 23, 2026
HOSE:DCL Ratios and Metrics
Market cap in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 3,283,194 | 3,140,764 | 1,953,848 | 1,826,026 | 1,789,505 | 2,341,546 | |
Market Cap Growth | 55.00% | 60.75% | 7.00% | 2.04% | -23.58% | 63.49% |
Enterprise Value | 3,627,981 | 3,737,025 | 2,496,432 | 2,143,061 | 1,536,107 | 2,681,631 |
Last Close Price | 44950.00 | 43000.00 | 26750.00 | 25000.00 | 24500.00 | 39800.00 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | 160.93 | 37.89 | 30.58 | 16.47 | 27.89 |
PS Ratio | 2.59 | 2.38 | 1.50 | 1.60 | 1.76 | 3.33 |
PB Ratio | 2.16 | 2.07 | 1.30 | 1.26 | 1.29 | 2.43 |
P/TBV Ratio | 2.22 | 2.12 | 1.34 | 1.30 | 1.32 | 2.63 |
P/OCF Ratio | 26.17 | 65.72 | 27.99 | 81.05 | - | 79.54 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.86 | 2.83 | 1.91 | 1.87 | 1.51 | 3.81 |
EV/EBITDA Ratio | 40.58 | 33.52 | 25.45 | 19.66 | 9.23 | 22.15 |
EV/EBIT Ratio | 104.87 | 63.90 | 41.73 | 30.30 | 11.97 | 30.90 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.50 | 0.51 | 0.50 | 0.44 | 0.37 | 0.52 |
Debt / EBITDA Ratio | 8.50 | 6.98 | 7.70 | 5.79 | 3.09 | 4.13 |
Net Debt / Equity Ratio | 0.21 | 0.43 | 0.40 | 0.35 | 0.25 | -0.06 |
Net Debt / EBITDA Ratio | 3.63 | 5.85 | 6.10 | 4.70 | 2.12 | -0.48 |
Net Debt / FCF Ratio | 48.05 | -16.20 | -5.81 | -2.56 | -0.51 | 0.47 |
Asset Turnover | 0.51 | 0.55 | 0.56 | 0.52 | 0.52 | 0.39 |
Inventory Turnover | 2.81 | 3.17 | 3.10 | 2.75 | 2.35 | 1.84 |
Quick Ratio | 1.10 | 1.15 | 1.29 | 1.33 | 1.50 | 1.22 |
Current Ratio | 1.99 | 2.03 | 2.19 | 2.27 | 2.57 | 1.77 |
Return on Equity (ROE) | -0.11% | 1.33% | 3.67% | 4.37% | 9.59% | 9.07% |
Return on Assets (ROA) | 0.88% | 1.51% | 1.59% | 2.02% | 4.13% | 3.03% |
Return on Invested Capital (ROIC) | -0.24% | 1.58% | 2.32% | 3.04% | 7.73% | 8.10% |
Return on Capital Employed (ROCE) | 2.00% | 3.30% | 3.40% | 4.30% | 8.30% | 8.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -0.07% | 0.62% | 2.74% | 3.38% | 6.24% | 3.67% |
FCF Yield | 0.21% | -1.28% | -5.27% | -10.97% | -38.17% | -5.26% |
Buyback Yield / Dilution | - | - | - | -4.11% | -22.02% | -1.17% |
Total Shareholder Return | - | - | - | -4.11% | -22.02% | -1.17% |